| ID | Name | CAS | Properties |
MW (g/mol) |
| 112-755-9 |
4H-Cyclopenta[b]thiophene-3-carboxylic acid, 2-amino-5,6-dihydro-, ethyl ester
|
4815-29-6 |
3 | 211.28 |
| 112-843-1 |
O-Methyl-O-(1,1-difluoro-2-bromoethyl)-N-(1-methylpropyl)-phosphorothioamidate
|
|
3 | 326.14 |
| 113-060-9 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-ethyl-phosphorothioamidate
|
|
3 | 267.66 |
| 113-064-5 |
11H-Pyrido[2,1-b]quinazolin-11-one, 6,7,8,9-tetrahydro, 8-methyl
|
|
3 | 214.26 |
| 113-127-5 |
Ethyl ([1,1,3,3,5,5-hexamethyl-5-(pyridin-3-ylmethoxy)trisiloxanyl]oxy)acetate
|
|
3 | 417.68 |
| 113-240-9 |
L-Proline, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 257.33 |
| 113-250-8 |
5-(4-Oxopentanoyl)-6-methyl-2,3-dihydro-1H-pyrrolizine
|
|
3 | 219.28 |
| 113-309-3 |
2-Naphthaleneacetic acid, 6-methoxy-«alpha»-methyl-, trimethylsilyl ester, (+)-
|
|
3 | 302.45 |
| 113-394-9 |
PYRROLO[1,2-A]PYRAZINE-1,4-DIONE, HEXAHYDRO-3-(PHENYLMETHYL)-
|
|
3 | 244.29 |
| 113-501-9 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, hexyl ester
|
|
3 | 453.42 |
| 113-526-2 |
11H-Pyrido[2,1-b]quinazolin-11-one, 6,7,8,9-tetrahydro, 6-methyl
|
|
3 | 214.27 |
| 113-677-5 |
5-[2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-hydroxy-propyl]-2-methoxy-phenol, TMS
|
|
3 | 502.79 |
| 113-944-8 |
Methyl 5-«beta»-cholan-7-«alpha»-ol-3-one-24-oate, oxime, TMS # 2
|
|
3 | 563.96 |
| 113-962-8 |
3«beta»,17,21«alpha»-Tris(trimethylsiloxy)pregn-5-ene
|
41164-19-6 |
3 | 551.04 |
| 113-995-2 |
O-Methyl-O-(1,1-difluoro-2-bromoethyl)-N-propyl-phosphorothioamidate
|
|
3 | 312.12 |
| 114-057-2 |
7,8,9,10-Tetrahydro-6H-azepino[2,1-b]quinazolin-12-one
|
|
3 | 214.26 |
| 114-194-0 |
2,2,2-Trifluoro-N-(6-Methoxy-1,3-benzothiazol-2-yl)acetamide
|
|
3 | 276.24 |
| 114-211-0 |
Cyclopentane-1,2-dione, 3,3,5,5-tetramethyl, bis(o-methyloxime)-(E,E)-
|
140210-44-2 |
3 | 212.29 |
| 114-271-4 |
6.alpha.-hydroxy-pregn-4-ene-3,20-dione, MO-TMS, anti
|
|
3 | 460.73 |
| 114-274-1 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, EO TMS #1
|
|
3 | 612.09 |
| 114-295-8 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, undecyl ester
|
|
3 | 457.53 |
| 114-306-5 |
Pyridine, 1-acetyl-5-(1-formyl-2-piperidinyl)-1,2,3,4-tetrahydro-
|
54966-16-4 |
3 | 236.31 |
| 114-345-2 |
Benzo[g]pyrido[2,3d]pyrimidin-2,4-dione,3,7,8,10-tetramethyl-
|
70239-57-5 |
3 | 269.30 |
| 114-419-0 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, pentyl ester
|
|
3 | 373.37 |
| 114-454-1 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-(3-methylbutyl)-phosphorothioamidate
|
|
3 | 295.71 |
| 114-455-0 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)pentyloxy-
|
|
3 | 298.54 |
| 114-488-4 |
2-Propanone, 1-[4-(1-methyl-2-pyrrolidinyl)-1-methyl-2-pyrrolidinyl]-
|
|
3 | 224.34 |
| 114-534-2 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, heptyl ester
|
|
3 | 467.45 |
| 114-536-0 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, heptadecyl ester
|
|
3 | 607.71 |
| 114-572-0 |
2,6-Pyridinedicarboxylic acid, 2-chloro-6-fluorophenyl 2-methylhex-3-yl ester
|
|
3 | 393.84 |
| 114-834-9 |
Silane, methylvinyl(hept-4-yloxy)(methylvinyl(hept-4-yloxy)silyloxy)-
|
|
3 | 386.72 |
| 114-884-4 |
O-(2-Chloro-1,1-difluoroethyl)-N-(1-methylpropyl)amidoethanethionophosphonate
|
|
3 | 279.71 |
| 114-900-5 |
R,S-3',4'-methylenedioxy-«alpha»-pyrrolidinopropiophenone-M (desmethylene-3-methyl-oxo-), ethylated
|
|
3 | 291.34 |
| 114-902-3 |
D-Proline, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 257.33 |
| 114-918-6 |
1,3-Propanediol, 2,2-dimethyl-, bis(cyclic 2,2-dimethyltrimethylene phosphorothionate
|
|
3 | 432.48 |
| 115-035-5 |
Cyclohexanecarboxylic acid, 4-[3-(2-chloroethyl )-3-nitrosoureido]-, ethyl ester,trans-
|
|
3 | 305.76 |
| 115-134-5 |
2-([(Dimethylamino)methylene]amino)-3-(3-chloro-4-ethyloxy-phenyl)propanoic acid, ethyl ester
|
|
3 | 326.82 |
| 115-176-9 |
Silane, [[(3«alpha»,5«beta»,20R)-pregnane-3,20-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
|
65598-77-8 |
3 | 549.03 |
| 115-256-0 |
1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, decahydro-4-(2-propenyl)-, [1S-(1«alpha»,4«alpha»,5«alpha»,11a«alpha»)]-
|
|
3 | 234.34 |
| 115-295-7 |
Silane, methylvinyl(4-methylpent-2-yloxy)(methylvinyl(4-methylpent-2-yloxy)silyloxy)-
|
|
3 | 358.66 |
| 115-416-2 |
1,3,2-Diazaphosphol-4-ene, 2-ethyl-2-oxo-1,3-dibutyl-4,5-dimethyl-
|
104728-29-2 |
3 | 272.37 |
| 115-546-8 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, undecyl ester
|
|
3 | 523.55 |
| 115-569-3 |
2-Nonenoic acid, 4-hydroxy, TMS, methyl ester, # 1
|
|
3 | 258.43 |
| 115-668-3 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, octyl ester
|
|
3 | 381.46 |
| 115-700-6 |
N-(4-Morpholin-4-yl-phenyl)-2-nitro-benzenesulfonamide, N-methyl-
|
|
3 | 377.42 |
| 115-734-9 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, pentyl ester
|
|
3 | 339.38 |
| 115-735-8 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, isohexyl ester
|
|
3 | 353.40 |
| 115-839-3 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, isobutyl ester
|
|
3 | 325.35 |
| 115-841-0 |
Thiazolo[3,2-a]pyridinium, 3,8-dihydroxy-2-phenyl-, hydroxide, inner salt
|
35143-57-8 |
3 | 243.28 |
| 115-861-8 |
4-(2,2'-Bithiophen-5-yl)but-3-yn-1-yl acetate
|
1219-28-9 |
3 | 276.37 |
| 115-901-3 |
3-Amino-3-(2-chlorophenyl)propionic acid, N-dimethylaminomethylene-, ethyl ester
|
|
3 | 282.77 |
| 115-936-5 |
3.alpha.-hydroxy-pregn-4-en-20-one, MO-TMS
|
|
3 | 417.71 |
| 115-953-6 |
Imidazolo[1,2-a]pyrimidine-2,5(1H,3H)-dione, 3,7-dimethyl-
|
53854-19-6 |
3 | 179.18 |
| 116-016-5 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-allyl-phosphorothioamidate
|
|
3 | 265.65 |
| 116-075-0 |
4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-6-(trifluoromethyl)-
|
368-54-7 |
3 | 196.15 |
| 116-216-3 |
2,5,5-Triethyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 212.29 |
| 116-220-8 |
Benzo[g]pteridine-2,4(3H,10H)-dione, 3,7,8,10-tetramethyl-
|
|
3 | 270.29 |
| 116-500-7 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N,N-diethyl-phosphorothioamidate
|
|
3 | 281.69 |
| 116-542-1 |
1,3-Thiazine-6-one-4-ol, 2-(3,4-dimethoxyphenyl)-
|
|
3 | 265.29 |
| 116-555-7 |
1,3,5(10)-Oestratriene-3,17.beta.-diol, 3-TBDMS-17-PFP
|
|
3 | 532.67 |
| 116-566-5 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-diphenyl, 1,3-bis-(chloromethyl)
|
|
3 | 415.46 |
| 116-693-4 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, heptyl ester
|
|
3 | 401.42 |
| 116-695-2 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, nonyl ester
|
|
3 | 429.48 |
| 116-696-1 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, isohexyl ester
|
|
3 | 387.39 |
| 116-901-2 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, isohexyl ester
|
|
3 | 453.42 |
| 116-913-9 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-isopropyl-phosphorothioamidate
|
|
3 | 267.66 |
| 116-976-0 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-(1-methylbutyl)-phosphorothioamidate
|
|
3 | 309.74 |
| 117-279-3 |
Benzo[g]pteridine-2,4(3H,10H)-dione,3,6,10-trimethyl-
|
70481-66-2 |
3 | 256.26 |
| 117-376-5 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-ethyl-phosphorothioamidate
|
|
3 | 253.63 |
| 117-418-8 |
N-(6-Methoxy-1,3-benzothiazol-2-yl)-2,2,3,3,4,4,4-heptafluorobutanamide
|
|
3 | 376.25 |
| 117-668-1 |
4H-Cyclopenteno[2,3-e]pyrido[1.2-a]pyrimidin-4-one
|
|
3 | 184.20 |
| 117-678-0 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-isopropyl-phosphorothioamidate
|
|
3 | 281.69 |
| 117-721-1 |
Galathan, 1,2,3,12,15,16-hexadehydro-9,10-[methylenebis(oxy)]-
|
641-89-4 |
3 | 251.28 |
| 117-776-1 |
Silane, methylvinyl(pent-2-yloxy)(methylvinyl(pent-2-yloxy)silyloxy)-
|
|
3 | 330.62 |
| 117-794-1 |
5,6-Dihydro-1,4,2-dioxazin-3-yl)-(2-hydroxyphenyl)methanone oxime, isomer 1
|
|
3 | 224.21 |
| 117-950-7 |
3H-Pyrimidin-4-one, 2,3-pentamethyleno-5,6-tetramethyleno
|
|
3 | 218.29 |
| 117-993-0 |
Methyl 5-«alpha»-cholan-3-one-24-oate, oxime, TMS # 2
|
|
3 | 475.78 |
| 118-095-6 |
Methyl 5-«alpha»-cholan-3-one-24-oate, oxime, TMS # 1
|
|
3 | 475.78 |
| 118-108-1 |
2-Methyl-5,5-pentamethylene-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 210.27 |
| 118-118-0 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N,N-diethyl-phosphorothioamidate
|
|
3 | 295.71 |
| 118-132-4 |
1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-8-(phenylmethyl)-
|
2879-15-4 |
3 | 270.29 |
| 118-135-1 |
2-Methyl-1,2,3,4,9,13b-hexahydro-2,4a-diaza-tribenzo[a,c,E]cyclohepten-7-ol, acetate
|
|
3 | 322.40 |
| 118-309-8 |
11H-Pyrido[2,1-b]quinazolin-11-one, 1,2,3,4,6,7,8,9-octahydro, 8-methyl
|
|
3 | 218.29 |
| 118-407-9 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-(1,1-dimethylethyl)-phosphorothioamidate
|
|
3 | 281.69 |
| 118-425-9 |
3H-Pyrimidin-4-one, 2,3:5,6-bis-hexamethyleno
|
|
3 | 260.37 |
| 118-453-8 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, propyl ester
|
|
3 | 345.31 |
| 118-576-2 |
1-Propanone, 2-methyl-1-[4-(methylthio)phenyl]-2-(4-morpholinyl)-
|
71868-10-5 |
3 | 279.40 |
| 118-774-2 |
1-(8-Bromo-dibenzo[1,2-b; 4,5-b']difuran-4-yl-2-aminoethane, TFA
|
|
3 | 376.12 |
| 118-847-1 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, butyl ester
|
|
3 | 325.35 |
| 118-873-2 |
Methyl 1,1'-dimethyl-2-oxo-1',4a',5',5a',7',8',10',10a'-octahydrospiro[indoline-3,6'-pyrano[3,4-f]indolizine]-4'-carboxylate
|
13897-71-7 |
3 | 382.45 |
| 118-995-7 |
1H-Purine-2,6-dione, 3,7-dihydro-8-(hydroxymethyl)-1,3-dimethyl-
|
|
3 | 210.19 |
| 119-138-7 |
5-pregnene-3«beta»,16«alpha»,20«alpha»-triol, MO-TMS
|
|
3 | 551.04 |
| 119-239-5 |
11H-Pyrido[2,1-b]quinazolin-11-one, 6,7,8,9-tetrahydro, 7-methyl
|
|
3 | 214.27 |
| 119-265-6 |
Lycorenan-7-one, 5-hydroxy-1-methyl-9,10-[methylenebis(oxy)]-, (5«alpha»)-
|
477-17-8 |
3 | 315.32 |
| 119-326-8 |
5-Hydroxy-5-methyl-2,3-bis-(1-pyrrolidinyl)-2-cyclopenten-1-one
|
|
3 | 250.34 |
| 119-564-4 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, decyl ester
|
|
3 | 509.52 |
| 119-566-2 |
Silane, methylvinyl(oct-4-yloxy)(methylvinyl(oct-4-yloxy)silyloxy)-
|
|
3 | 414.77 |
| 119-626-5 |
Silane, dimethyl(dimethyl(dimethyl(2-hexyloxy)silyloxy)silyloxy)(2-hexyloxy)-
|
|
3 | 408.80 |
| 119-661-6 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-isobutyl-phosphorothioamidate
|
|
3 | 295.71 |
| 119-736-3 |
Pentan-2-one, 4-methyl-4-ethoxyamino, O-ethyloxime, anty
|
|
3 | 202.29 |
|
« Previous Results
Next Results »
|